Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus
出版年份 2023 全文链接
标题
Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus
作者
关键词
-
出版物
JOURNAL OF DIABETES AND ITS COMPLICATIONS
Volume 37, Issue 11, Pages 108629
出版商
Elsevier BV
发表日期
2023-10-18
DOI
10.1016/j.jdiacomp.2023.108629
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains
- (2023) Zheng Shen et al. BIOMEDICINE & PHARMACOTHERAPY
- Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes
- (2023) Savita Bansal et al. World Journal of Diabetes
- Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot
- (2022) Wang Liao et al. Frontiers in Pharmacology
- Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice
- (2022) Priya Balasubramanian et al. eLife
- AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice
- (2022) Mayuri Khandelwal et al. NEUROBIOLOGY OF DISEASE
- Glimepiride ameliorates renal toxicity induced by cadmium in mice: Modulation of Jun N terminal kinase (JNK)/nuclear factor kappa B (NF-κB) and phosphatidylinositol 3-kinases (PI3K)/protein kinase (AKT) pathways
- (2022) Mohamed Kh. ElMahdy et al. LIFE SCIENCES
- AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice
- (2021) Masato Iwabu et al. Communications Biology
- Protective properties of GLP‐1 and associated peptide hormones in neurodegenerative disorders
- (2021) Christian Hölscher BRITISH JOURNAL OF PHARMACOLOGY
- Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo
- (2021) Sonja Lindfors et al. DIABETOLOGIA
- A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease
- (2021) Natalia Kyrtata et al. Frontiers in Neuroscience
- GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer’s disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway
- (2021) Yunzhen Xie et al. BIOCHEMICAL PHARMACOLOGY
- Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
- (2021) A Young Sim et al. Frontiers in Neuroscience
- Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
- (2021) Saghar Rabiei Poor et al. Pharmaceuticals
- Intranasal insulin administration may be highly effective in improving cognitive function in mice with cognitive dysfunction by reversing brain insulin resistance
- (2020) Hui Lv et al. Cognitive Neurodynamics
- AdipoRon improves cognitive dysfunction of Alzheimer’s disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway
- (2020) Bin Liu et al. EXPERIMENTAL NEUROLOGY
- Adiponectin and Cognitive Decline
- (2020) Maria Rosaria Rizzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model
- (2020) Partow Mirzaee Saffari et al. LIFE SCIENCES
- Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis
- (2020) Jian-Bo Zhou et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway
- (2020) Daqian Gu et al. Clinical and Experimental Nephrology
- Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway
- (2020) Liying Yang et al. LIFE SCIENCES
- Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
- (2020) Che‐Yuan Wu et al. Alzheimers & Dementia
- Cellular and Molecular Mechanisms of Metformin Action
- (2020) Traci E LaMoia et al. ENDOCRINE REVIEWS
- Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer’s Disease
- (2020) Jong Youl Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antioxidant/Anti-Inflammatory Effects of Caloric Restriction in an Aged and Obese Rat Model: The Role of Adiponectin
- (2020) Daniele La Russa et al. Biomedicines
- Metformin Therapy Aggravates Neurodegenerative Processes in ApoE– /– Mice
- (2019) Angela Kuhla et al. JOURNAL OF ALZHEIMERS DISEASE
- Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives
- (2019) Hidekatsu Yanai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin treatment improves the spatial memory of the aged mice in an APOE genotype–dependent manner
- (2019) Jing Zhang et al. FASEB JOURNAL
- Molecular and cellular bases of diabetes: Focus on type 2 diabetes mouse model-TallyHo
- (2019) Kavya Tamarai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
- (2019) Grazia Daniela Femminella et al. Trials
- Crucial players in Alzheimer’s disease and diabetes mellitus: Friends or foes?
- (2019) AM. Kubis-Kubiak et al. MECHANISMS OF AGEING AND DEVELOPMENT
- High molecular weight adiponectin reduces glucolipotoxicity-induced inflammation and improves lipid metabolism and insulin sensitivity via APPL1-AMPK-GLUT4 regulation in 3T3-L1 adipocytes
- (2019) Gautam Kumar Pandey et al. ATHEROSCLEROSIS
- A comparison study on efficacy, insulin sensitivity and safety of Glimepiride/Metformin fixed dose combination versus glimepiride single therapy on type 2 diabetes mellitus patients with basal insulin therapy
- (2019) Hea Min Yu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes
- (2019) Laura I. Hudish et al. JOURNAL OF CLINICAL INVESTIGATION
- New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling
- (2019) Alejandra Tomas et al. JOURNAL OF MOLECULAR BIOLOGY
- AdipoRon Attenuates Neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway
- (2019) Jingwei Zheng et al. NEUROSCIENCE
- Altered Insulin Signaling in Alzheimer’s Disease Brain – Special Emphasis on PI3K-Akt Pathway
- (2019) Sami Gabbouj et al. Frontiers in Neuroscience
- The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes
- (2018) Yaeni Kim et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
- (2018) Steven E. Arnold et al. Nature Reviews Neurology
- Current progress on peroxisome proliferator-activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer's disease: An update
- (2018) Mahmood Ahmad Khan et al. Current Neuropharmacology
- AMPK Activation Ameliorates Alzheimer's Disease-Like Pathology and Spatial Memory Impairment in a Streptozotocin-Induced Alzheimer's Disease Model in Rats
- (2018) Lai-Ling Du et al. JOURNAL OF ALZHEIMERS DISEASE
- Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment
- (2018) Min Li et al. Frontiers in Physiology
- Neural correlates of liraglutide effects in persons at risk for Alzheimer’s disease
- (2018) Kathleen T. Watson et al. BEHAVIOURAL BRAIN RESEARCH
- Glucagon-Like Peptide 1 in the Brain: Where Is It Coming From, Where Is It Going?
- (2018) Derek Daniels et al. DIABETES
- Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance
- (2018) Jin-Liang Chen et al. EXPERIMENTAL NEUROLOGY
- Insulin Resistance in Alzheimer's Disease
- (2018) Laís S. S. Ferreira et al. Frontiers in Neuroscience
- Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
- (2017) Suzanne Craft et al. JOURNAL OF ALZHEIMERS DISEASE
- Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus
- (2017) Muhammad Sajid Hamid Akash et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels
- (2016) Henry H. Ruiz et al. Alzheimers & Dementia
- Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice
- (2016) Wilma Helena Oliveira et al. BRAIN RESEARCH
- Impact of Insulin Sensitizers on the Incidence of Dementia: A Meta-Analysis
- (2016) Fang Ye et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Perspectives in GLP-1 Research: New Targets, New Receptors
- (2016) Giulia Cantini et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus
- (2015) Sabrina Prudente et al. AMERICAN JOURNAL OF HUMAN GENETICS
- State of the art paper Sulfonylureas and their use in clinical practice
- (2015) Daniele Sola et al. Archives of Medical Science
- DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
- (2015) Edy Kornelius et al. CNS Neuroscience & Therapeutics
- Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions
- (2014) Anusha Jayaraman et al. Current Diabetes Reports
- Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors
- (2014) B. Omar et al. DIABETES
- Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
- (2014) Laurie L. Baggio et al. JOURNAL OF CLINICAL INVESTIGATION
- The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
- (2014) Moritz M. Hettich et al. PLoS One
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons
- (2013) Feiyang Liu et al. NEUROSCIENCE LETTERS
- Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases
- (2013) Morihiro Matsuda et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies
- (2013) Kapil Gudala et al. Journal of Diabetes Investigation
- GLP1 and cancer: friend or foe?
- (2012) Roman Vangoitsenhoven et al. ENDOCRINE-RELATED CANCER
- MicroRNAs: a new ray of hope for diabetes mellitus
- (2012) Munish Kumar et al. Protein & Cell
- Adiponectin receptor signalling in the brain
- (2011) John Thundyil et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glucose tolerance status and risk of dementia in the community: The Hisayama Study
- (2011) T. Ohara et al. NEUROLOGY
- Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
- (2011) Kyeong Won Lee et al. Diabetes & Metabolism Journal
- Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer’s disease
- (2010) K. Une et al. EUROPEAN JOURNAL OF NEUROLOGY
- Adiponectin and adiponectin receptor system in the rat adrenal gland: Ontogenetic and physiologic regulation, and its involvement in regulating adrenocortical growth and steroidogenesis
- (2010) Lukasz Paschke et al. PEPTIDES
- The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer’s Disease
- (2009) Qingguang Jiang et al. CNS DRUGS
- Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
- (2009) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- APPL1: role in adiponectin signaling and beyond
- (2008) Sathyaseelan S. Deepa et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-κB activation through a phosphoinoside 3-kinase-Akt-dependent pathway
- (2008) T. Jojima et al. DIABETES OBESITY & METABOLISM
- Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease
- (2008) Hong Ma et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Thiazolidinediones: effects on insulin resistance and the cardiovascular system
- (2007) C E Quinn et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now